Orexo AB (publ)
ORXOF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.09 | -0.01 | 0.07 | -0.01 |
| FCF Yield | 0.00% | -0.20% | 8.80% | 1.31% |
| EV / EBITDA | -136.33 | -72.07 | 125.21 | 23.30 |
| Quality | ||||
| ROIC | -7.16% | -7.08% | -1.26% | -26.22% |
| Gross Margin | 84.50% | 92.89% | 85.84% | 86.09% |
| Cash Conversion Ratio | 0.03 | -6.33 | -0.06 | 0.61 |
| Growth | ||||
| Revenue 3-Year CAGR | -11.39% | -3.96% | -1.44% | -1.86% |
| Free Cash Flow Growth | 0.00% | -102.13% | 509.26% | 140.30% |
| Safety | ||||
| Net Debt / EBITDA | -39.36 | -37.06 | 61.83 | 10.72 |
| Interest Coverage | -1.90 | -1.75 | -0.37 | -7.90 |
| Efficiency | ||||
| Inventory Turnover | 0.43 | 0.20 | 0.57 | 0.37 |
| Cash Conversion Cycle | 7.70 | -142.32 | 107.34 | 209.76 |